Literature DB >> 24109409

2-Hy-droxy-methyl-1,3-dimethyl-1H-imidazol-3-ium triiodide.

Mohamed El Hadi Said1, Abdelmalek Bouraiou, Sofiane Bouacida, Hocine Merazig, Ali Belfaitah, Aissa Chibani.   

Abstract

The crystal packing of the title salt, C6H11N2O(+)·I3 (-), can be described as consisting of alternating layers of cations and anions parallel to the (100) plane along the a-axis direction. The components are linked by O-H⋯I, C-H⋯I and C-H⋯O interactions, generating a three-dimensional network. The O atom deviates from the imidazol ring by 0.896 (2) Å.

Entities:  

Year:  2013        PMID: 24109409      PMCID: PMC3793822          DOI: 10.1107/S1600536813020266

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the importance of heterocyclic compounds and their applications, see: Pandey et al. (2009 ▶); Nasser (2000 ▶). For the biological activity of imidazole and imidazolium derivatives, see: Ucucu et al. (2001 ▶); Dominianni et al. (1989 ▶); Ozkay et al. (2010 ▶). For our previous work on imidazole derivatives, see: Bahnous et al. (2012 ▶); Zama et al. (2013 ▶); Chelghoum et al. (2011 ▶).

Experimental

Crystal data

C6H11N2O+·I3 − M = 507.87 Monoclinic, a = 7.1647 (8) Å b = 15.5586 (19) Å c = 11.3201 (13) Å β = 96.026 (7)° V = 1254.9 (3) Å3 Z = 4 Mo Kα radiation μ = 7.44 mm−1 T = 150 K 0.24 × 0.03 × 0.02 mm

Data collection

Bruker APEXII diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 2002 ▶) T min = 0.781, T max = 1.000 7061 measured reflections 2222 independent reflections 2104 reflections with I > 2σ(I) R int = 0.022

Refinement

R[F 2 > 2σ(F 2)] = 0.015 wR(F 2) = 0.034 S = 1.15 2222 reflections 112 parameters H-atom parameters constrained Δρmax = 0.45 e Å−3 Δρmin = −0.47 e Å−3 Data collection: APEX2 (Bruker, 2006 ▶); cell refinement: SMART (Bruker, 2006 ▶); data reduction: SMART; program(s) used to solve structure: SIR2002 (Burla et al., 2005 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶) and DIAMOND (Brandenburg & Berndt, 2001 ▶); software used to prepare material for publication: WinGX (Farrugia, 2012) ▶ and CRYSCAL (T. Roisnel, local program). Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536813020266/hg5333sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813020266/hg5333Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S1600536813020266/hg5333Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C6H11N2O+·I3F(000) = 912
Mr = 507.87Dx = 2.688 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 5058 reflections
a = 7.1647 (8) Åθ = 2.2–25.1°
b = 15.5586 (19) ŵ = 7.44 mm1
c = 11.3201 (13) ÅT = 150 K
β = 96.026 (7)°Stick, brown
V = 1254.9 (3) Å30.24 × 0.03 × 0.02 mm
Z = 4
Bruker APEXII diffractometer2104 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.022
CCD rotation images, thin slices scansθmax = 25.1°, θmin = 2.6°
Absorption correction: multi-scan (SADABS; Sheldrick, 2002)h = −8→8
Tmin = 0.781, Tmax = 1.000k = −18→18
7061 measured reflectionsl = −13→13
2222 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.015Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.034H-atom parameters constrained
S = 1.15w = 1/[σ2(Fo2) + 1.5935P] where P = (Fo2 + 2Fc2)/3
2222 reflections(Δ/σ)max = 0.001
112 parametersΔρmax = 0.45 e Å3
0 restraintsΔρmin = −0.47 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
I20.23583 (2)0.148350 (12)0.326494 (15)0.01269 (6)
I10.19816 (3)−0.006510 (12)0.171029 (17)0.01684 (6)
I30.25836 (3)0.297933 (14)0.474053 (18)0.02126 (6)
N20.7383 (3)0.17050 (16)0.3419 (2)0.0144 (5)
O10.8099 (3)0.15052 (14)0.09130 (18)0.0177 (5)
H10.91190.12860.08330.027*
N10.7438 (3)0.03209 (16)0.3568 (2)0.0141 (5)
C20.7275 (4)0.09763 (19)0.2795 (3)0.0132 (6)
C50.7344 (4)−0.0598 (2)0.3266 (3)0.0209 (7)
H5A0.61−0.07380.2920.031*
H5B0.7643−0.09330.39720.031*
H5C0.8227−0.07230.27070.031*
C60.7239 (4)0.2584 (2)0.2943 (3)0.0196 (7)
H6A0.84210.27510.26860.029*
H6B0.69180.29710.35510.029*
H6C0.62850.26050.22820.029*
C30.7663 (4)0.0651 (2)0.4703 (3)0.0195 (7)
H30.78110.03360.54050.023*
C40.7630 (4)0.1512 (2)0.4610 (3)0.0171 (7)
H40.77510.19040.52340.021*
C10.6972 (4)0.0911 (2)0.1468 (3)0.0160 (6)
H1A0.72690.03320.12280.019*
H1B0.5660.10180.12040.019*
U11U22U33U12U13U23
I20.01199 (10)0.01601 (11)0.01018 (10)−0.00047 (7)0.00176 (7)0.00073 (7)
I10.02125 (11)0.01258 (11)0.01685 (11)−0.00009 (8)0.00283 (8)−0.00207 (8)
I30.02175 (11)0.02351 (12)0.01884 (12)−0.00312 (8)0.00360 (8)−0.00943 (8)
N20.0138 (12)0.0121 (13)0.0176 (14)0.0021 (10)0.0039 (10)0.0011 (11)
O10.0196 (10)0.0200 (12)0.0144 (11)−0.0001 (9)0.0058 (8)0.0043 (9)
N10.0139 (12)0.0159 (13)0.0122 (12)−0.0006 (10)0.0008 (9)0.0034 (11)
C20.0075 (13)0.0149 (15)0.0172 (15)0.0021 (11)0.0017 (11)0.0017 (12)
C50.0276 (17)0.0114 (16)0.0234 (17)0.0011 (13)0.0022 (13)0.0032 (13)
C60.0235 (16)0.0124 (16)0.0239 (17)0.0016 (13)0.0075 (13)0.0029 (13)
C30.0193 (15)0.0275 (19)0.0117 (15)0.0002 (13)0.0021 (12)0.0025 (13)
C40.0182 (15)0.0213 (17)0.0127 (15)−0.0006 (13)0.0054 (12)−0.0039 (13)
C10.0158 (14)0.0176 (16)0.0141 (15)−0.0007 (12)−0.0004 (11)0.0042 (13)
I2—I32.8594 (4)C5—H5A0.96
I2—I12.9792 (4)C5—H5B0.96
N2—C21.334 (4)C5—H5C0.96
N2—C41.374 (4)C6—H6A0.96
N2—C61.470 (4)C6—H6B0.96
O1—C11.417 (3)C6—H6C0.96
O1—H10.82C3—C41.344 (5)
N1—C21.341 (4)C3—H30.93
N1—C31.377 (4)C4—H40.93
N1—C51.470 (4)C1—H1A0.97
C2—C11.499 (4)C1—H1B0.97
I3—I2—I1178.026 (8)N2—C6—H6B109.5
C2—N2—C4109.2 (3)H6A—C6—H6B109.5
C2—N2—C6126.8 (3)N2—C6—H6C109.5
C4—N2—C6124.0 (3)H6A—C6—H6C109.5
C1—O1—H1109.5H6B—C6—H6C109.5
C2—N1—C3108.6 (3)C4—C3—N1107.4 (3)
C2—N1—C5126.1 (3)C4—C3—H3126.3
C3—N1—C5125.3 (3)N1—C3—H3126.3
N2—C2—N1107.7 (3)C3—C4—N2107.1 (3)
N2—C2—C1125.7 (3)C3—C4—H4126.4
N1—C2—C1126.6 (3)N2—C4—H4126.4
N1—C5—H5A109.5O1—C1—C2111.7 (2)
N1—C5—H5B109.5O1—C1—H1A109.3
H5A—C5—H5B109.5C2—C1—H1A109.3
N1—C5—H5C109.5O1—C1—H1B109.3
H5A—C5—H5C109.5C2—C1—H1B109.3
H5B—C5—H5C109.5H1A—C1—H1B107.9
N2—C6—H6A109.5
C4—N2—C2—N10.4 (3)C2—N1—C3—C40.2 (3)
C6—N2—C2—N1−178.8 (2)C5—N1—C3—C4−178.4 (3)
C4—N2—C2—C1178.8 (3)N1—C3—C4—N20.1 (3)
C6—N2—C2—C1−0.4 (4)C2—N2—C4—C3−0.3 (3)
C3—N1—C2—N2−0.4 (3)C6—N2—C4—C3179.0 (3)
C5—N1—C2—N2178.2 (2)N2—C2—C1—O144.3 (4)
C3—N1—C2—C1−178.7 (3)N1—C2—C1—O1−137.6 (3)
C5—N1—C2—C1−0.2 (4)
D—H···AD—HH···AD···AD—H···A
O1—H1···I1i0.823.033.741 (2)146
C1—H1B···I3ii0.973.053.924 (3)151
C4—H4···O1iii0.932.603.421 (4)148
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
O1—H1⋯I1i 0.823.033.741 (2)146
C1—H1B⋯I3ii 0.973.053.924 (3)151
C4—H4⋯O1iii 0.932.603.421 (4)148

Symmetry codes: (i) ; (ii) ; (iii) .

  8 in total

1.  Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity.

Authors:  Yusuf Ozkay; Ilhan Işikdağ; Zerrin Incesu; Gülşen Akalin
Journal:  Eur J Med Chem       Date:  2010-04-18       Impact factor: 6.514

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Synthesis and analgesic activity of some 1-benzyl-2-substituted-4,5-diphenyl-1H-imidazole derivatives.

Authors:  O Uçucu; N G Karaburun; I Işikdağ
Journal:  Farmaco       Date:  2001-04

4.  Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings.

Authors:  Sarvesh Kumar Pandey; Abhishek Singh; Ashutosh Singh
Journal:  Eur J Med Chem       Date:  2008-06-03       Impact factor: 6.514

5.  Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides.

Authors:  S J Dominianni; T T Yen
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

6.  Methyl 2-(2-methyl-4-nitro-1H-imidazol-1-yl)acetate.

Authors:  Sana Zama; Abdelmalek Bouraiou; Sofiane Bouacida; Thierry Roisnel; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-04

7.  2-Hy-droxy-methyl-1,3-dimethyl-imidazolium iodide.

Authors:  Meryem Chelghoum; Mebarek Bahnous; Sofiane Bouacida; Thierry Roisnel; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-02

8.  4,5-Dibromo-1,2-dimethyl-1H-imidazol-3-ium bromide.

Authors:  Mebarek Bahnous; Abdelmalek Bouraiou; Sofiane Bouacida; Thierry Roisnel; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.